Omega-3 Fatty Acids: The Complete Guide to EPA, DHA, ALA — Sources, Benefits and How Much You Need

Inadequate omega-3 intake is not a niche concern. The Global Burden of Disease Study 2016, led by Gakidou et al. and published in The Lancet, identified low seafood omega-3 intake as one of the top dietary risk factors for mortality worldwide, contributing to an estimated 1.6 million deaths annually — primarily through cardiovascular disease. In Western nations, typical EPA and DHA consumption sits far below the 250–500 mg per day recommended by most international health bodies. Surveys conducted in the United Kingdom and United States consistently show that fewer than 20 percent of adults meet even minimal omega-3 targets through diet alone. Meanwhile, the ratio of omega-6 to omega-3 fatty acids in the average Western diet has risen from an estimated ancestral 4:1 to somewhere between 15:1 and 20:1, a shift with meaningful implications for systemic inflammation, platelet aggregation and lipid metabolism. The consequences fall disproportionately on populations with the lowest fish consumption, pregnant women whose fetuses require DHA for neural development, and older adults experiencing age-related cognitive decline. Understanding omega-3s is therefore not a matter of optimisation for elite athletes — it is a baseline nutrition priority relevant to almost every adult.

There are three dietary omega-3 fatty acids worth understanding. Alpha-linolenic acid (ALA) is a short-chain omega-3 found predominantly in plant foods. It is an essential fatty acid, meaning the body cannot synthesise it and must obtain it from food. However, humans convert ALA to the longer-chain EPA and DHA only inefficiently — conversion rates range from roughly 5–8 percent to EPA and less than 1 percent to DHA under normal physiological conditions, according to established metabolic tracer studies. Eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) are long-chain omega-3s found mainly in marine sources. They exert the majority of the health effects attributed to omega-3s. A landmark 2011 JAMA review by Mozaffarian and Wu examined the biological mechanisms comprehensively: EPA and DHA lower triglycerides by 15–30 percent at doses above 2 g per day, reduce resting heart rate, modestly lower blood pressure, improve arterial compliance and reduce platelet aggregation. A 2013 Nutrients review by Philip Calder detailed how EPA is the primary substrate for producing anti-inflammatory eicosanoids — prostaglandins, thromboxanes and leukotrienes of the 3-series — in direct competition with the pro-inflammatory arachidonic acid pathway. DHA, meanwhile, constitutes 30–40 percent of the phospholipid content of brain grey matter and is critical for maintaining synaptic membrane fluidity and neurotransmitter receptor function. A 2021 Mayo Clinic Proceedings meta-analysis by Bernasconi et al. pooling data from 40 randomised controlled trials found that higher omega-3 doses (above 1 g per day of EPA+DHA) were associated with significantly greater reductions in major adverse cardiovascular events, with each additional gram associated with an incremental 5.8 percent relative risk reduction. The evidence for cardiovascular benefit is rated as strong; evidence for cognitive protection as moderate; evidence for mood support as preliminary.

Certain groups are at substantially greater risk of falling short of adequate EPA and DHA. Vegans and vegetarians who avoid fish and seafood consume almost no preformed EPA or DHA; they rely entirely on the inefficient ALA-to-DHA conversion pathway. Pregnant and breastfeeding women have dramatically elevated DHA requirements — the developing fetal brain accumulates approximately 70 mg of DHA per day in the third trimester. Low maternal DHA is associated with preterm birth and suboptimal infant neurodevelopment. Older adults absorb dietary fats less efficiently and may have compromised conversion capacity due to reduced desaturase enzyme activity. People with type 2 diabetes show impaired ALA conversion, making marine-source omega-3s especially important. Populations in landlocked regions or low-income settings where oily fish is expensive or inaccessible face structural barriers to adequate intake. Those with cardiovascular disease or significantly elevated triglycerides (above 5.6 mmol/L) are a group where prescription-strength omega-3 therapy — at doses of 2–4 g EPA+DHA per day — has the clearest evidence base. Conversely, individuals who regularly eat two to three servings of oily fish weekly may obtain sufficient EPA and DHA through diet and may not require supplementation at all.

Marine sources provide preformed EPA and DHA and are by far the most efficient dietary route. Oily fish top the list: Atlantic mackerel (2.5 g EPA+DHA per 100 g), wild-caught salmon (1.8–2.2 g per 100 g), sardines in their own oil (1.4 g per 100 g), herring (1.7 g per 100 g), and anchovies (1.5 g per 100 g). Tinned fish retains most of its omega-3 content, making it a cost-effective option. Farmed salmon contains high omega-3 levels but the EPA+DHA concentration varies with feed composition; wild-caught Atlantic salmon generally has a more favourable omega-6 to omega-3 ratio. Cod, haddock, tilapia and most shellfish (except oysters and mussels) are lean white fish and provide minimal EPA and DHA. ALA-rich plant foods include ground flaxseed (2.4 g ALA per tablespoon), chia seeds (5 g ALA per tablespoon), walnuts (2.6 g ALA per 30 g), hemp seeds (0.9 g ALA per tablespoon) and rapeseed (canola) oil (1.3 g ALA per tablespoon). These are valuable contributions but should not be assumed equivalent to marine sources. Algae-derived DHA oil is the exception — it provides preformed DHA from the original source in the marine food chain and is an effective vegan alternative; some algae oils also contain EPA. Foods to limit because they displace omega-3s from the diet include refined seed oils high in omega-6 (sunflower, corn, soybean), ultra-processed foods containing these oils, and large predatory fish (swordfish, shark, king mackerel) where mercury accumulation may offset benefit.

Monday: Breakfast — overnight oats with ground flaxseed and walnuts; Dinner — baked salmon fillet with roasted vegetables and brown rice. Tuesday: Breakfast — scrambled eggs with smoked mackerel and wholegrain toast; Lunch — sardine and rocket salad with lemon vinaigrette. Wednesday: Breakfast — chia seed pudding with berries; Dinner — trout en papillote with capers, dill and new potatoes. Thursday: Breakfast — porridge with hemp seeds; Dinner — pasta with anchovies, garlic, cherry tomatoes and olive oil. Friday: Breakfast — walnut and banana smoothie with added flaxseed; Dinner — herring fillets with wholegrain mustard, watercress and roasted beetroot. Saturday: Lunch — tinned mackerel on sourdough with sliced cucumber and red onion; Dinner — homemade fish cakes made with salmon, served with a green salad. Sunday: Breakfast — smoked salmon and poached eggs on rye bread; Dinner — oysters or mussels to start, followed by baked cod with walnut crust. This plan delivers approximately 1.5–2.5 g EPA+DHA on days with oily fish and meaningful ALA on all days. On non-fish days, a fish oil or algae oil supplement of 500 mg EPA+DHA bridges the gap. Calorie and macronutrient targets should be adjusted to individual requirements in consultation with a registered dietitian.

Myth 1: All omega-3s are the same. This is incorrect. ALA from flaxseed and DHA from salmon are both omega-3s but have entirely different physiological roles and bioavailability. Citing flaxseed as a replacement for fish oil is nutritionally misleading for most people. Myth 2: Eating fish every day is dangerous because of mercury. For most adults and children, the benefits of two to three portions of oily fish per week substantially outweigh the mercury risk. Mercury concern is most relevant for large predatory species and is especially important for pregnant women to avoid, but salmon, sardines, mackerel and anchovies are universally considered low-mercury choices. Myth 3: The omega-3 in fish oil supplements is as good as fresh fish. The evidence base for cardiovascular benefit is primarily built on dietary fish consumption and in some large trials on high-dose prescription omega-3 ethyl esters. Over-the-counter fish oil in standard doses shows more mixed results in recent RCTs, possibly because dose, formulation and baseline dietary omega-3 status matter. Myth 4: If some omega-3 is good, more is always better. At very high doses (above 3 g per day), omega-3 supplementation can increase LDL cholesterol and at extreme doses may impair immune function. The REDUCE-IT trial using 4 g per day of icosapentaenoic acid (pure EPA) showed major cardiovascular benefit, but this was a pharmaceutical-grade product in a high-risk population — not a rationale for megadosing over-the-counter supplements. Myth 5: Plant-based diets can easily meet omega-3 needs through flaxseed and chia. While these foods are excellent ALA sources, the conversion efficiency to DHA is too low for most vegans to rely on without algae oil supplementation, a point often understated in plant-based nutrition advocacy.

The decision to supplement should be grounded in dietary assessment and, ideally, objective measurement. An omega-3 index test — measuring EPA+DHA as a percentage of total red blood cell fatty acids — is the most clinically meaningful biomarker; a target of 8–12 percent is associated with lowest cardiovascular risk, while most Western adults test at 4–5 percent. For general health maintenance in adults who eat oily fish twice weekly, supplementation is likely unnecessary. For those with little or no fish intake, a standard supplement of 500 mg–1 g EPA+DHA daily is a reasonable starting point. For elevated triglycerides or established cardiovascular disease, a healthcare provider should guide dosing, potentially up to 2–4 g EPA+DHA per day. When choosing a supplement, look for: (1) third-party testing certification (IFOS, NSF, USP), (2) triglyceride form or re-esterified triglyceride form rather than ethyl ester, as these show superior absorption in most studies, (3) a combined EPA+DHA concentration above 500 mg per capsule to avoid needing to take many capsules, (4) freshness indicated by a low peroxide value (under 5 meq/kg) — rancid fish oil is oxidised and may be harmful rather than beneficial. Algae-derived omega-3 supplements are the preferred option for vegans, vegetarians and those with fish allergy; they are also more environmentally sustainable. Refrigerate all fish oil supplements after opening. Do not exceed 3 g per day of combined EPA+DHA without medical supervision, as higher doses can affect bleeding time.

Omega-3 status is rarely tested in standard lipid panels, but it is worth requesting if you have cardiovascular risk factors, elevated triglycerides or significant cognitive concerns. Key tests to discuss: an omega-3 index test (commercially available through services like OmegaQuant), a standard fasting lipid panel including triglycerides, and a fasting glucose or HbA1c if metabolic risk is present. What the numbers mean: triglycerides below 1.7 mmol/L (150 mg/dL) are optimal; levels above 5.6 mmol/L (500 mg/dL) significantly increase pancreatitis risk and typically warrant prescription omega-3 therapy. Discuss your current fish consumption honestly — many clinicians are unaware how low population intake actually is. If you are on anticoagulant medication such as warfarin or a direct oral anticoagulant, inform your prescriber before starting high-dose omega-3 supplementation, as additive effects on bleeding are theoretically possible (though clinical trial data on this interaction are reassuring at standard doses). Frequency of testing: once baseline lipids are established, annual checks are appropriate for most adults. Those on therapeutic omega-3 doses should recheck triglycerides and lipid panels after 3 months to assess response.